Results 41 to 50 of about 1,927 (190)

Mécanismes et conséquences des mutations [PDF]

open access: yes, 2005
L’identification des mutations à l’origine de maladies génétiques chez l’homme a pris ces dernières années un essor considérable. Il est devenu possible d’établir le spectre des mutations délétères pour une maladie génétique donnée, et des bases de ...
Hanna, Nadine   +3 more
core   +1 more source

Socially oriented attention in young children with neurofibromatosis type 1: An eye‐tracking study

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 4, Page 541-548, April 2026.
Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.70050 Abstract Aim To examine visual engagement to social stimuli and response to joint attention in young children with neurofibromatosis type 1 (NF1) and typically developing peers (controls). Method Forty‐five preschool children were studied cross‐sectionally (mean age [SD] = 4 
Kristina M. Haebich   +6 more
wiley   +1 more source

Neurofibromatose tipo 1: a propósito de um caso clínico [PDF]

open access: yes, 2013
A neurofibromatose é uma doença neurocutânea, genética, autossómica dominante. crónica e progressiva. Tem sido observada em todas as raças e em ambos os sexos.
Ascensão, Ana   +4 more
core  

GABA deficiency in NF1: a multimodal [11C]-Flumazenil and spectroscopy study [PDF]

open access: yes, 2016
Objective: To provide a comprehensive investigation of the GABA system in patients with Neurofibromatosis type 1 (NF1) that allows understanding the nature of the GABA imbalance in humans at pre- and post-synaptic levels. Methods: In this cross-sectional
Abrunhosa, AJ   +6 more
core   +1 more source

Interventions supporting the empowerment of parent carers of children with neurodisability and other long‐term health conditions: A scoping review

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 4, Page 489-500, April 2026.
This scoping review identified 145 different interventions designed to support parent carer empowerment. These interventions have been catalogued and are presented in an interactive, online database. Abstract Aim To compile information about interventions that have been developed to support the empowerment of parent carers of children and young people ...
Jim Reeder   +7 more
wiley   +1 more source

L'atteinte vésicale au cours de la neurofibromatose de Von Recklinghausen

open access: yesThe Pan African Medical Journal, 2014
La neurofibromatose de type 1 ou maladie de Von Recklinghausen est une maladie génétique autosomique dominante en rapport avec des mutations dans le gène suppresseur de tumeur NF1. L'atteinte uro-génitale au cours de cette maladie est rare et moins de 80
Mohamed Hicham Benazzouz   +6 more
doaj   +1 more source

Case for diagnosis [PDF]

open access: yes, 2011
O termo úlcera de Marjolin é usado para designar a transformação maligna que se origina na pele cronicamente lesada. Trata-se de neoplasia mais agressiva do que aquelas não relacionadas com cicatriz e, frequentemente, é subdiagnosticada ou tratada de ...
ALMEIDA, José Roberto Paes de   +4 more
core   +3 more sources

Cognitive deficits in children with neurofibromatosis Type I: from recognition to treatment [PDF]

open access: yes, 2008
__Abstract__ Over the past few years, mouse models have significantly contributed to our understanding of the molecular mechanisms underlying cognitive dysfunction in genetic disorders.
Krab, L.C. (Lianne)
core  

Grande tache pigmentée pileuse révélant une forme familiale de la maladie de Von Recklinghausen

open access: yesThe Pan African Medical Journal, 2015
La neurofibromatose de type 1 (NF1) ou maladie de Von Recklinghausen appartient au groupe de maladies appelé phacomatose. C'est une affection autosomique dominante relativement rare.
Anass Es seddiki   +4 more
doaj   +1 more source

Nanodroplet‐Array‐Plattform zur integrierten Synthese und Screening von MEK Inhibitoren: Ein miniaturisierter Ansatz für die frühe Pharmaforschung

open access: yesAngewandte Chemie, Volume 137, Issue 48, November 24, 2025.
Wir präsentieren eine Nanodroplet‐Array‐Plattform, die die Integration von Festphasensynthese, MALDI‐MS‐Analyse und zellbasiertem Screening von 325 potenziellen MEK‐Inhibitoren (Mitogen‐aktivierte‐Proteinkinase‐Kinase) in Nanoliter‐Volumina ermöglicht.
Maximilian Seifermann   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy